Literature DB >> 2525378

Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin.

C Kluft1, A F Jie, P Los, E de Wit, L Havekes.   

Abstract

Apolipoprotein(a), apo(a), contains 37 repeats structurally homologous to kringle 4 structures of the fibrinolysis zymogen plasminogen. The aim of the study was to explore the functional analogy between apolipoprotein(a) and plasminogen in the binding to the kringle-4-binding plasma protein, tetranectin. With a modified crossed immunoelectrophoresis technique, reversible binding between lipoprotein(a) and tetranectin could be demonstrated with an apparent Kd of 0.013 muMol/l. Lys- and Glu-plasminogen showed an apparent Kd of 0.5 muMol/l. Binding of lipoprotein(a) to fibrin and to fibrin-bound tetranectin was found to be negligible. The absence of fibrin binding of lipoprotein(a) excludes a potential mechanism of coexistence of fibrin and lipid deposits in arterial diseases and does not provide for a link between lipoprotein and the clotting system. Plasminogen and lipoprotein(a) show functional analogy in their binding to tetranectin, but tetranectin primarily targets at lipoprotein(a).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2525378     DOI: 10.1016/0006-291x(89)92616-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.

Authors:  O Klezovitch; C Edelstein; A M Scanu
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Zinc-dependent dimers observed in crystals of human endostatin.

Authors:  Y H Ding; K Javaherian; K M Lo; R Chopra; T Boehm; J Lanciotti; B A Harris; Y Li; R Shapiro; E Hohenester; R Timpl; J Folkman; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

3.  Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis.

Authors:  Weiqiang Chen; Xiaoling Qiang; Yongjun Wang; Shu Zhu; Jianhua Li; Ariella Babaev; Huan Yang; Jonathan Gong; Lance Becker; Ping Wang; Kevin J Tracey; Haichao Wang
Journal:  Sci Transl Med       Date:  2020-04-15       Impact factor: 17.956

4.  Tetranectin in slow intra- and extrafusal chicken muscle fibers.

Authors:  X Xu; B Gilpin; K Iba; A Maier; E Engvall; R Albrechtsen; U M Wewer
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

5.  Expression and prognostic significance of Tetranectin in invasive and non-invasive bladder cancer.

Authors:  A Brunner; C Ensinger; M Christiansen; S Heiss; I Verdorfer; G Mikuz; A Tzankov
Journal:  Virchows Arch       Date:  2007-04-13       Impact factor: 4.064

6.  The heparin-binding site in tetranectin is located in the N-terminal region and binding does not involve the carbohydrate recognition domain.

Authors:  R H Lorentsen; J H Graversen; N R Caterer; H C Thogersen; M Etzerodt
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

7.  Lipoprotein (a) in type 2 diabetes mellitus: Relation to LDL:HDL ratio and glycemic control.

Authors:  Seema Singla; Kiranjeet Kaur; Gurdeep Kaur; Habir Kaur; Jasbinder Kaur; Shivani Jaswal
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

8.  Comparative analysis of serum proteomes: Identification of proteins associated with sciatica due to lumbar intervertebral disc herniation.

Authors:  Peigen Xie; Bin Liu; Ruiqiang Chen; Bu Yang; Jianwen Dong; Limin Rong
Journal:  Biomed Rep       Date:  2014-06-16

9.  Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis.

Authors:  E F Kamper; L T Kopeikina; P Trontzas; N C Kyriazis; G Vaiopoulos; J Stavridis
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

10.  Aberrant tetranectin expression in human breast carcinomas as a predictor of survival.

Authors:  P Obrist; G Spizzo; C Ensinger; D Fong; T Brunhuber; G Schäfer; M Varga; R Margreiter; A Amberger; G Gastl; M Christiansen
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.